t, confident outlook (trading +2.0%) • Qinetiq H1 better in difficult market, considering sale of US unit, reiterates forecasts (trading +7.3%) • Mothercare H1 revs improving, EPS better, international good, consumer remains subdued (trading -2.2%) • Medivir O3 revs strong y/y, EBITDA better, EPS okay,